These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7690228)

  • 1. The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.
    Alhainen K; Helkala EL; Reinikainen K; Riekkinen P
    J Neural Transm Park Dis Dement Sect; 1993; 5(3):185-92. PubMed ID: 7690228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.
    Martignoni E; Bono G; Blandini F; Sinforiani E; Merlo P; Nappi G
    J Neural Transm Park Dis Dement Sect; 1991; 3(1):15-25. PubMed ID: 1712206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD; Geracioti TD; Altemus M; Kling MA
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease.
    Sjögren M; Minthon L; Passant U; Blennow K; Wallin A
    Neurobiol Aging; 1998; 19(5):379-84. PubMed ID: 9880039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
    Blennow K; Wallin A; Gottfries CG; Månsson JE; Svennerholm L
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):5-15. PubMed ID: 7679905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
    Bråne G; Gottfries CG; Blennow K; Karlsson I; Lekman A; Parnetti L; Svennerholm L; Wallin A
    Alzheimer Dis Assoc Disord; 1989; 3(3):148-56. PubMed ID: 2477044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
    Nybäck H; Nyman H; Schalling D
    Acta Psychiatr Scand; 1987 Dec; 76(6):648-56. PubMed ID: 2450445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
    Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L
    Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
    Jolkkonen J; Helkala EL; Kutvonen R; Lehtinen M; Riekkinen PJ
    Psychoneuroendocrinology; 1989; 14(1-2):89-95. PubMed ID: 2471986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine metabolites in cerebrospinal fluid during and after acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ouyang S; Huang YQ
    Mol Chem Neuropathol; 1989 Apr; 10(2):77-85. PubMed ID: 2472800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.
    Blennow K; Wallin A; Gottfries CG; Karlsson I; Månsson JE; Skoog I; Wikkelsö C; Svennerholm L
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):55-61. PubMed ID: 7682460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF monoamine metabolites in relation to the diagnostic interview for borderline patients (DIB).
    Chotai J; Kullgren G; Asberg M
    Neuropsychobiology; 1998 Nov; 38(4):207-12. PubMed ID: 9813458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experiences and biochemical findings with tacrine (THA).
    Nybäck H; Hassan M; Junthé T; Ahlin A
    Acta Neurol Scand Suppl; 1993; 149():36-8. PubMed ID: 7510447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin and cognitive functions in Alzheimer's disease--the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine.
    Alhainen K; Sirviö J; Helkala EL; Reinikainen K; Riekkinen P
    Neurosci Lett; 1991 Sep; 130(1):46-8. PubMed ID: 1684233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
    Gibson CJ; Logue M; Growdon JH
    Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.